Human, animal, or adjacent evidence
This medication is commonly prescribed by doctors for the following conditions: Various peripheral neuropathies that can be influenced by the three vitamins, including: polyneuropathy, neuralgia, sciatica, lumbago (lower back pain), shoulder-arm syndrome, intercostal neuralgia, trigeminal neuralgia, numbness in the extremities,
Potential Benefits Increases aerobic capacity and endurance performance by activating the same metabolic pathways engaged during sustained aerobic exercise training
It also does not cause significant BPC-157 water retention, the way growth hormone or some anabolic compounds can
WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use
This neovascularization phenomenon was consistently observed in murine full-thickness burn injuries (Fig